385 related articles for article (PubMed ID: 31383289)
1. Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation.
Qin J; Wang R; Zhao C; Wen J; Dong H; Wang S; Li Y; Zhao Y; Li J; Yang Y; He X; Wang D
Tissue Cell; 2019 Aug; 59():51-61. PubMed ID: 31383289
[TBL] [Abstract][Full Text] [Related]
2. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
3. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.
Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
[TBL] [Abstract][Full Text] [Related]
4. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
6. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.
Silva G; Aboussekhra A
Mol Carcinog; 2016 May; 55(5):525-36. PubMed ID: 25728247
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma.
Dai G; Liu G; Zheng D; Song Q
Eur J Pharmacol; 2021 May; 899():174058. PubMed ID: 33757752
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate inhibits osteosarcoma cell invasiveness by inhibiting the MEK/ERK signaling pathway in human osteosarcoma cells.
Tang G; Zhang Z; Qian H; Chen J; Wang Y; Chen X; Chen B; Chen Y
J Environ Pathol Toxicol Oncol; 2015; 34(1):85-93. PubMed ID: 25746833
[TBL] [Abstract][Full Text] [Related]
9. Tomatidine Represses Invasion and Migration of Human Osteosarcoma U2OS and HOS Cells by Suppression of Presenilin 1 and c-Raf-MEK-ERK Pathway.
Hsieh MH; Yang JS; Lin RC; Hsieh YH; Yang SF; Chang HR; Lu KH
Molecules; 2020 Jan; 25(2):. PubMed ID: 31941156
[TBL] [Abstract][Full Text] [Related]
10. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
He J; Zhang W; Di T; Meng J; Qi Y; Li G; Zhang Y; Su H; Yan W
Biomed Pharmacother; 2020 Nov; 131():110541. PubMed ID: 33152901
[TBL] [Abstract][Full Text] [Related]
11. URG4 mediates cell proliferation and cell cycle in osteosarcoma via GSK3β/β-catenin/cyclin D1 signaling pathway.
Liu Y; Xi Y; Chen G; Wu X; He M
J Orthop Surg Res; 2020 Jun; 15(1):226. PubMed ID: 32552851
[TBL] [Abstract][Full Text] [Related]
12. WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway.
Wang X; Zhao X; Yi Z; Ma B; Wang H; Pu Y; Wang J; Wang S
Cell Biol Int; 2018 May; 42(5):598-607. PubMed ID: 29345412
[TBL] [Abstract][Full Text] [Related]
13. Baicalein inhibits cell development, metastasis and EMT and induces apoptosis by regulating ERK signaling pathway in osteosarcoma.
Lin H; Hao Y; Wan X; He J; Tong Y
J Recept Signal Transduct Res; 2020 Feb; 40(1):49-57. PubMed ID: 31948366
[No Abstract] [Full Text] [Related]
14. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
15. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract][Full Text] [Related]
16. NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/MAPK pathways.
Yao J; Weng Y; Yan S; Hou M; Wang H; Shi Q; Zuo G
Oncol Rep; 2015 Oct; 34(4):2011-21. PubMed ID: 26238193
[TBL] [Abstract][Full Text] [Related]
17. Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells.
Pan PJ; Tsai JJ; Liu YC
Anticancer Res; 2017 Sep; 37(9):4911-4918. PubMed ID: 28870912
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HSPB6 inhibits osteosarcoma progress through the ERK signaling pathway.
Guo L; Xiao K; Xie Y; Yang Z; Lei J; Cai L
Clin Exp Med; 2023 Dec; 23(8):5389-5398. PubMed ID: 37861934
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
[TBL] [Abstract][Full Text] [Related]
20. The role of Notch ligand Jagged1 in osteosarcoma proliferation, metastasis, and recurrence.
Zhang J; Li N; Lu S; Chen Y; Shan L; Zhao X; Xu Y
J Orthop Surg Res; 2021 Mar; 16(1):226. PubMed ID: 33781318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
